XML 59 R49.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Mar. 31, 2016
Jan. 31, 2016
May 31, 2015
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2013
Dec. 31, 2010
Related-Party Transactions (Textual) [Abstract]                      
Long-term other assets $ 2,639,354         $ 2,625,659   $ 2,625,659      
Contra-research and development expense           $ 2,600,000   $ 6,700,000      
GeneOne Life Sciences                      
Related-Party Transactions (Textual) [Abstract]                      
Investment owned (shares)           1,644,155   1,644,155      
Payment received for license granted                     $ 3,000,000
Term                   20 years  
Milestone-based ownership target       35.00% 35.00%            
Proceeds from sale of intangible assets 1,000,000                    
Revenue from related parties           $ 155,000 $ 104,000 $ 305,000 $ 426,000    
Operating expenses related to affiliated entity           1,900,000 704,000 4,700,000 1,900,000    
Accounts receivable 0         74,000   74,000      
Accounts payable and accrued liability 107,000         310,000   310,000      
Long-term other assets 331,000         312,000   312,000      
Director                      
Related-Party Transactions (Textual) [Abstract]                      
Term     5 years                
Revenue from related parties             708,000   2,400,000    
Operating expenses related to affiliated entity           615,000 596,000 1,400,000 1,600,000    
Accounts receivable 117,000         1,000,000   1,000,000      
Expenses to reimburse     $ 3,100,000                
Award   $ 6,100,000                  
Contra-research and development expense           952,000   3,200,000      
Accounts payable/accrued liabilities 820,000         381,000   381,000      
Plumbline Life Sciences                      
Related-Party Transactions (Textual) [Abstract]                      
Revenue from related parties           30,000 $ 25,000 88,000 $ 113,000    
Accounts receivable $ 370,000         $ 459,000   $ 459,000      
Plumbline Life Sciences | Available-for-sale Securities                      
Related-Party Transactions (Textual) [Abstract]                      
Investment owned (shares)           395,758   395,758